Aimei Health Technology Co., Ltd. reported a net income of $45,440 and diluted earnings per share of $0.01 for Q1 2026, marking a decline from $184,662 and $0.03 in the same period last year, with no operating revenue as the company remains a SPAC pending a business combination. The company has executed a definitive merger agreement with United Hydrogen, with shareholder approval secured and an effective F-4 registration statement, aiming for closure in late 2026. However, operational activities have been limited to IPO preparation, and completion of the merger is contingent on pending regulatory approvals, which could cause delays.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.tradingview.com/news/tradingview:4abfcb75aff40:0-aimei-health-technology-co-ltd-1q-2026-net-income-45-44k-eps-0-01-10-q-summary/
